Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates

Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of$ 0.35. This compares to a loss of $0.61 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.29%. A quarter ago, it was expected that this company would post a loss of$ 0.33 per share when it actually produced a loss of $0.48, delivering a surprise of -45.45%.Over the last four quarters, the comp ...